AJP - Endo Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 262: E447-E454, 1992;
0193-1849/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pelligrino, D. A.
Right arrow Articles by Albrecht, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pelligrino, D. A.
Right arrow Articles by Albrecht, R. F.

AJP - Endocrinology and Metabolism, Vol 262, Issue 4 E447-E454, Copyright © 1992 by American Physiological Society

ARTICLES

Diminished muscarinic receptor-mediated cerebral blood flow response in streptozotocin-treated rats

D. A. Pelligrino, D. J. Miletich and R. F. Albrecht
Department of Anesthesiology, University of Illinois-Chicago, Humana Hospital-Micheal Reese 60616.

Endothelium-dependent vascular relaxation in the brain may be impaired in the streptozotocin-treated chronically hyperglycemic diabetic (D) rat. To study this, we measured regional cerebral blood flow (rCBF) changes induced by intracarotid (ic) or intravenous (iv) infusions of the blood-brain permeant muscarinic receptor (MR) agonist oxotremorine (Oxo). In nondiabetic (ND) rats, both ic and iv Oxo resulted in significant (P less than 0.05) rCBF increases from values obtained during saline infusions in the regions analyzed. The maximum rCBF values measured during Oxo (expressed as percent iv or ic saline value) were 358-403% in the cortex (CX), 236-260% in the subcortex (SC), 162-186% in the brain stem (BS), and 143-158% in the cerebellum (CE). The iv or ic Oxo response in D vs. ND rats was reduced by 60-70% in the CX and SC, lost in the BS, and unchanged in the CE. The CBF response was associated with no change in cortical CMRO2 and was completely blocked during ic atropine-Oxo co-infusion or iv co-infusion of Oxo with the nitric oxide (NO) synthesis inhibitor L-nitroarginine methyl ester, demonstrating, respectively, no role for metabolic activation, the exclusive role of MR values, and the critical role for the release of the putative endothelium-dependent relaxation factor NO in mediating this effect. These findings indicate a significant, but regionally variable, impairment of the mechanism for endothelium-dependent vascular relaxation in the diabetic brain.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. G. Mayhan and K. P. Patel
Treatment with dimethylthiourea prevents impaired dilatation of the basilar artery during diabetes mellitus
Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1895 - H1901.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
G. M. Pieper
Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction
Hypertension, May 1, 1998; 31(5): 1047 - 1060.
[Full Text] [PDF]

Home page
 Physiol. Rev.Home page
F. M. FARACI and D. D. HEISTAD
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
Physiol Rev, January 1, 1998; 78(1): 53 - 97.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
C. S. Tietjen, J. R. Kirsch, N. Clavier, and R. J. Traystman
Time-Dependent Inhibition of Oxotremorine-Induced Cerebral Hyperemia by N{omega}-Nitro-L-Arginine in Cats
Stroke, November 1, 1995; 26(11): 2160 - 2165.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online